E Fund Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Sell |
|
|||||
|
2025
Q1 | $464K | Buy |
|
|||||
|
2024
Q4 | $464K | Sell |
|
|||||
|
2024
Q3 | $645K | Buy |
|
|||||
|
2024
Q2 | $599K | Buy |
|
|||||
|
2024
Q1 | $374K | Sell |
|
|||||
|
2023
Q4 | $592K | Buy |
|
|||||
|
2023
Q3 | $416K | Buy |
|
|||||
|
2023
Q2 | $409K | Sell |
|
|||||
|
2023
Q1 | $404K | Buy |
|
|||||
|
2022
Q4 | $351K | Buy |
|
|||||
|
2022
Q3 | $465K | Buy |
|
|||||
|
2022
Q2 | $417K | Buy |
|